SLC25A40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.58119961568559E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.96459999946397E-07 |
Normal-vs-Stage2 |
3.502100E-02 |
Normal-vs-Stage3 |
2.91322521661641E-13 |
Normal-vs-Stage4 |
1.26099997110884E-09 |
Stage1-vs-Stage2 |
5.874600E-01 |
Stage1-vs-Stage3 |
1.177760E-04 |
Stage1-vs-Stage4 |
4.336500E-03 |
Stage2-vs-Stage3 |
1.624180E-02 |
Stage2-vs-Stage4 |
3.106200E-02 |
Stage3-vs-Stage4 |
9.073600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.38790001713573E-09 |
Normal-vs-AfricanAmerican |
6.17028650395923E-12 |
Normal-vs-Asian |
4.960200E-02 |
Caucasian-vs-AfricanAmerican |
2.036000E-03 |
Caucasian-vs-Asian |
8.104400E-01 |
AfricanAmerican-vs-Asian |
1.259810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.10469999814455E-09 |
Normal-vs-Female |
4.10059997069112E-09 |
Male-vs-Female |
6.347400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.35129999999195E-05 |
Normal-vs-Age(41-60Yrs) |
4.80740000030622E-07 |
Normal-vs-Age(61-80Yrs) |
6.85880019446472E-10 |
Normal-vs-Age(81-100Yrs) |
4.05619999810369E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.457000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.748400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.366800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.097600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.029880E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.800200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.701900E-03 |
Normal-vs-Grade 2 |
2.89440000000862E-06 |
Normal-vs-Grade 3 |
2.52170506698235E-11 |
Normal-vs-Grade 4 |
1.66222591246878E-12 |
Grade 1-vs-Grade 2 |
8.581200E-01 |
Grade 1-vs-Grade 3 |
4.691000E-01 |
Grade 1-vs-Grade 4 |
4.298200E-02 |
Grade 2-vs-Grade 3 |
1.467830E-02 |
Grade 2-vs-Grade 4 |
1.62429999999159E-05 |
Grade 3-vs-Grade 4 |
1.650150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.40149999997108E-06 |
Normal-vs-ccB subtype |
3.90510000003452E-06 |
ccA subtype-vs-ccB subtype |
5.975800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.59480000106305E-08 |
Normal-vs-N1 |
8.044800E-03 |
N0-vs-N1 |
3.773600E-01 |
|
|